Armistice Capital’s Supernus Pharmaceuticals SUPN Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$152M	Sell	4,812,000 -384,000	-7%	-$12.1M	2.62%	2
2025 Q1	$170M	Buy	5,196,000 +360,000	+7%	+$11.8M	2.55%	2
2024 Q4	$175M	Sell	4,836,000 -260,000	-5%	-$9.4M	2.39%	2
2024 Q3	$159M	Sell	5,096,000 -176,000	-3%	-$5.49M	2.54%	2
2024 Q2	$141M	Buy	5,272,000 +1,700,000	+48%	+$45.5M	1.77%	2
2024 Q1	$122M	Sell	3,572,000 -1,078,000	-23%	-$36.8M	1.62%	4
2023 Q4	$135M	Sell	4,650,000 -442,000	-9%	-$12.8M	1.84%	3
2023 Q3	$140M	Buy	5,092,000 +56,000	+1%	+$1.54M	2.15%	1
2023 Q2	$151M	Buy	5,036,000 +686,000	+16%	+$20.6M	2.19%	2
2023 Q1	$158M	Sell	4,350,000 -6,000	-0.1%	-$217K	2.27%	3
2022 Q4	$155M	Sell	4,356,000 -237,004	-5%	-$8.45M	2.71%	2
2022 Q3	$155M	Sell	4,593,004 -118,996	-3%	-$4.03M	2.7%	2
2022 Q2	$136K	Buy	4,712,000 +1,612,000	+52%	+$46.6K	2.38%	5
2022 Q1	$100M	Sell	3,100,000 -1,036,000	-25%	-$33.5M	1.94%	8
2021 Q4	$121M	Buy	4,136,000 +236,000	+6%	+$6.88M	1.97%	5
2021 Q3	$104M	Buy	3,900,000 +576,000	+17%	+$15.4M	1.76%	8
2021 Q2	$102M	Sell	3,324,000 -88,000	-3%	-$2.71M	1.83%	6
2021 Q1	$89.3M	Buy	3,412,000 +292,000	+9%	+$7.64M	2.05%	4
2020 Q4	$78.5M	Sell	3,120,000 -80,000	-3%	-$2.01M	2.67%	2
2020 Q3	$66.7M	Buy	3,200,000 +992,000	+45%	+$20.7M	2.42%	2
2020 Q2	$52.4M	Sell	2,208,000 -792,000	-26%	-$18.8M	2.3%	9
2020 Q1	$54M	Buy	3,000,000 +1,288,000	+75%	+$23.2M	3.34%	2
2019 Q4	$40.6M	Buy	+1,712,000	New	+$40.6M	2.34%	4